To the full analysis
Ingredion stock: growth
INGRIngredion reported $7.22B in revenue for fiscal 2025, down 2.8% on the prior year, up 3.8% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
5.5%
per year from 2006 to 2025, per share 6.3%
Earnings (Annual rate)
9.8%
per year from 2006 to 2025, per share 10.6%
Free cash flow (Annual rate)
12%
per year from 2006 to 2025, per share 12.9%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 3.8% | 1.9% | 5.5% |
| Revenue per share | 4.8% | 3.1% | 6.3% |
| Earnings | 15.9% | 6.1% | 9.8% |
| Earnings per share | 17.0% | 7.3% | 10.6% |
| Free cash flow | 0.9% | 2.3% | 12.0% |
| Free cash flow per share | 1.8% | 3.4% | 12.9% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $2.62B | $124M | $59M |
| 2007 | $3.39B | $198M | $81M |
| 2008 | $3.94B | $267.2M | −$298M |
| 2009 | $3.67B | $41.1M | $445M |
| 2010 | $4.37B | $169.2M | $238M |
| 2011 | $6.22B | $415.7M | $40M |
| 2012 | $6.87B | $427.5M | $428M |
| 2013 | $6.65B | $395.7M | $324M |
| 2014 | $6B | $354.9M | $460M |
| 2015 | $5.96B | $402.2M | $409M |
| 2016 | $6.02B | $484.9M | $488M |
| 2017 | $6.18B | $519M | $463M |
| 2018 | $6.29B | $443M | $354M |
| 2019 | $6.21B | $413M | $352M |
| 2020 | $5.99B | $348M | $489M |
| 2021 | $6.89B | $117M | $92M |
| 2022 | $7.95B | $492M | −$148M |
| 2023 | $8.16B | $643M | $741M |
| 2024 | $7.43B | $647M | $1.14B |
| 2025 | $7.22B | $729M | $511M |
Revenue by region
Where Ingredion Incorporated generates its revenue.
- United States39%
- Mexico19%
- Brazil8%
- Canada7%
- Germany5%
- Colombia4%
- Other17%
“Other” combines smaller regions with revenue the company does not assign to a region.
Figures as a table
| 2024 | 2025 | Share 2025 | |
|---|---|---|---|
| United States | $2.87B | $2.82B | 39% |
| Mexico | $1.5B | $1.39B | 19.3% |
| Brazil | $584M | $572M | 7.9% |
| Canada | $527M | $495M | 6.9% |
| Germany | $385M | $384M | 5.3% |
| Colombia | $310M | $324M | 4.5% |
| Other | $1.25B | $1.24B | 17.1% |
| Total revenue | $7.43B | $7.22B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 14 Aug 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.